Results 131 to 140 of about 3,052,066 (346)
Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran [PDF]
Abbas Rezaianzadeh +5 more
openalex +1 more source
Return to Work of Breast Cancer Survivors: Perspectives and Challenges for Occupational Physicians [PDF]
Marcello Campagna +3 more
openalex +1 more source
LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix +13 more
wiley +1 more source
Social cognitive influences on physical activity participation in long‐term breast cancer survivors
Siobhan M. Phillips, Edward McAuley
openalex +1 more source
Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li +10 more
wiley +1 more source
Evaluating Preoperative Anxiety Levels in Patients Undergoing Breast Cancer Surgery
Maria Katsohiraki +7 more
openalex +1 more source
When to order a biopsy to characterise a metastatic relapse in breast cancer [PDF]
Theodoros Foukakis +4 more
openalex +1 more source
Immediate versus secondary DIEP flap breast reconstruction: a multicenter outcome study [PDF]
Lukas Prantl +9 more
openalex +1 more source
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff +11 more
wiley +1 more source
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source

